SpacDeskPOINT Biopharma Global Inc.
Completed deSPAC · 1 SPAC · 1 closed · 0 announced
Therapeutics Acquisition Corp (Nasdaq: RACA), a blank-check company sponsored by RTW Investments, LP — a dedicated life sciences investment manager — completed its merger with POINT Biopharma Global Inc. following a deal announcement in March 2021. RACA conducted its IPO in 2020 and targeted the biotechnology and pharmaceutical sector, ultimately combining with POINT Biopharma, an Indianapolis-based radiopharmaceutical company developing targeted radioligand therapies for oncology indications. The transaction closed in 2021, with POINT Biopharma subsequently trading on Nasdaq under the ticker PNT. The deal marked one of several SPAC-driven entries into the radiopharmaceutical space during that period. Visit SpacDesk and sign up for full data, filings, and analytics on this and hundreds of other SPAC transactions.
SPAC Counterparty (1)
| Symbol | Issuer | Status | Announced | Close | IPO Size | PIPE | Sponsor |
|---|---|---|---|---|---|---|---|
| RACA | Therapeutics Acquisition Corp | Closed | 2021-03-15 | 2021-07-01 | $165.0M | $165.0M | RA Capital |